[Oxaliplatin -- A 10-Year Trajectory].

Area of Science:

• Oncology
• Pharmacology

Background:

• Oxaliplatin is a third-generation platinum derivative used in chemotherapy.
• International clinical trials have established its efficacy across four indications.
• Significant research in Japan has expanded the evidence base for oxaliplatin.

Purpose of the Study:

• To review the 10-year trajectory of oxaliplatin use in Japan.
• To analyze the accumulated evidence on oxaliplatin's clinical applications.
• To consider the future potential of oxaliplatin in cancer treatment.

Main Methods:

• Literature review of international and Japanese clinical trials.
• Analysis of evidence accumulation and clinical application data.
• Discussion of oxaliplatin's evolving role in oncology.

Main Results:

• Oxaliplatin has demonstrated established efficacy in multiple cancer indications.
• Japanese research has contributed significantly to the understanding of oxaliplatin's use.
• A decade of data provides a foundation for future therapeutic strategies.

Conclusions:

• Oxaliplatin remains a key agent in cancer chemotherapy.
• Continued research and evidence development are crucial for optimizing its use.
• Future applications may expand based on ongoing investigations and clinical experience.